Financial Health Check: Examining Conduit Pharmaceuticals Inc (CDT)’s Key Ratios

Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.

Conduit Pharmaceuticals Inc (NASDAQ: CDT) closed the day trading at $1.15 down -3.36% from the previous closing price of $1.19. In other words, the price has decreased by -$3.36 from its previous closing price. On the day, 0.59 million shares were traded.

Ratios:

For a better understanding of CDT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.12 and its Current Ratio is at 0.12.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 03 ’24 when Nirland Ltd sold 1,500,000 shares for $0.10 per share. The transaction valued at 156,450 led to the insider holds 8,400,000 shares of the business.

Nirland Ltd sold 1,368,991 shares of CDT for $140,458 on Oct 04 ’24. The 10% Owner now owns 7,031,009 shares after completing the transaction at $0.10 per share. On Oct 07 ’24, another insider, Nirland Ltd, who serves as the 10% Owner of the company, sold 939,009 shares for $0.10 each. As a result, the insider received 96,530 and left with 6,092,000 shares of the company.

Stock Price History:

Over the past 52 weeks, CDT has reached a high of $392.00, while it has fallen to a 52-week low of $1.13. The 50-Day Moving Average of the stock is -78.83%, while the 200-Day Moving Average is calculated to be -98.03%.

Shares Statistics:

A total of 0.96M shares are outstanding, with a floating share count of 0.72M. Insiders hold about 39.68% of the company’s shares, while institutions hold 7.29% stake in the company.

Most Popular